Defining Multimorbidity and Its Impact in Older United States Veterans Newly Treated for Multiple Myeloma
Open Access
- 1 February 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 113 (8) , 1084-1093
Abstract
Traditional count-based measures of comorbidity are unlikely to capture the complexity of multiple chronic conditions (multimorbidity) in older adults with cancer. We aimed to define patterns of multimorbidity and their impact in older United States veterans with multiple myeloma (MM). We measured 66 chronic conditions in 5076 veterans aged 65 years and older newly treated for MM in the national Veterans Affairs health-care system from 2004 to 2017. Latent class analysis was used to identify patterns of multimorbidity among these conditions. These patterns were then assessed for their association with overall survival, our primary outcome. Secondary outcomes included emergency department visits and hospitalizations. Five patterns of multimorbidity emerged from the latent class analysis, and survival varied across these patterns (log-rank 2-sided P < .001). Older veterans with cardiovascular and metabolic disease (30.9%, hazard ratio [HR] = 1.33, 95% confidence interval [CI] = 1.21 to 1.45), psychiatric and substance use disorders (9.7%, HR = 1.58, 95% CI = 1.39 to 1.79), chronic lung disease (15.9%, HR = 1.69, 95% CI = 1.53 to 1.87), and multisystem impairment (13.8%, HR = 2.25, 95% CI = 2.03 to 2.50) had higher mortality compared with veterans with minimal comorbidity (29.7%, reference). Associations with mortality were maintained after adjustment for sociodemographic variables, measures of disease risk, and the count-based Charlson Comorbidity Index. Multimorbidity patterns were also associated with emergency department visits and hospitalizations. Our findings demonstrate the need to move beyond count-based measures of comorbidity and consider cancer in the context of multiple chronic conditions.Keywords
Funding Information
- VA Office of Research and Development
- Cooperative Studies Program (1R33AG057806)
- Harvard Translational Research in Aging Training Program
- National Institute on Aging
- National Institutes of Health (T32AG023480)
- VA Merit Review Award (1I01BX001584)
- NIH (P01-155258–07, P50-100707)
- Department of Veterans Affairs
- VA Health Services Research and Development Service
- VA Information Resource Center (SDR 02–237, 98–004)
This publication has 47 references indexed in Scilit:
- The impact of comorbidity on cancer survival: a reviewClinical Epidemiology, 2013
- Managing patients with multimorbidity: systematic review of interventions in primary care and community settingsBMJ, 2012
- Review of methods used to measure comorbidity in cancer populations: No gold standard existsJournal of Clinical Epidemiology, 2012
- Comorbidity as a prognostic variable in multiple myeloma: comparative evaluation of common comorbidity scores and use of a novel MM–comorbidity scoreBlood Cancer Journal, 2011
- A Dynamic Network Approach for the Study of Human PhenotypesPLOS Computational Biology, 2009
- Mild Traumatic Brain Injury in U.S. Soldiers Returning from IraqNew England Journal of Medicine, 2008
- Co-morbidity does not reflect complexity in internal medicine patientsEuropean Journal of Internal Medicine, 2007
- International Staging System for Multiple MyelomaJournal of Clinical Oncology, 2005
- Review of 1027 Patients With Newly Diagnosed Multiple MyelomaMayo Clinic Proceedings, 2003
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987